Company Quick10K Filing
Lixte Biotechnology Holdings
10-Q 2020-09-30 Filed 2020-11-10
S-1 2020-09-03 Public Filing
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-25
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-25
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-04-27
10-K 2017-12-31 Filed 2018-03-23
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-29
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-10
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-03-21
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-05
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-29
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-28
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-10
10-Q 2010-03-31 Filed 2010-05-04
10-K 2009-12-31 Filed 2010-03-29
8-K 2020-11-25
8-K 2020-08-12
8-K 2020-07-15
8-K 2020-07-14
8-K 2019-07-31
8-K 2018-11-30
8-K 2018-11-05
8-K 2018-08-20
8-K 2018-08-04

Lixte Biotechnology Holdings Financials

LIXT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Banner Energy Services Corp. (BANM)
AVIENT CORP (AVNT)
11 Good Energy (ELVN)
COWEN INC. (COWNL)
1347 Capital Corp (TFSC)
CAI International, Inc. (CAI-PA)
Avianca Holdings S.A. (AVHOQ)
Gamco Investors (GBL) 505,641 0% 4.3 45% 179,495 146,777 307,065 0 80,872 102,868 443,648
BANK BRADESCO (BBDO)
BIO-RAD LABORATORIES, INC. (BIO-B)
Fortress Transportation & Infrastructure Investors LLC (FTAI-PC)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Intevac (IVAC) 106,629 33% -678.8 -3% 124,284 35,098 73,440 24,374 -4,054 -133 90,277
1st United Bancorp (FUBC)
CIT GROUP INC (CIT-PB)
2-Track Global (TTG)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3413014692,1771,8811,6551,3751,075791475115479441401272182599966702008712,0321,5901,3068085363744,2733,8943,5642,976
Accounts Receivable
Inventory
PP&E
Assets1,4211,0014302022,2551,9621,7531,4811,1458745581881,3029965391,6821,5251,0275981,2251,3799344339212,0651,6511,3688555834454,3373,9553,6193,066
Accounts Payable
Long-Term Debt
Liabilities337362351467351246261270266294322284327402273254198222286193140196219254242256373239338459211245223309
Stockholders' Equity1,08463879-2661,9031,7151,4921,211879580236-969755942661,4281,3278053121,0321,2397382156661,8231,395995616244-144,1263,7103,3962,756
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000000000000002000000000000
Cost of Revenue66666
Gross Profit-6
R&D224364485274217394128166249220245163336309310506287624675264317477243303137206104264134880571
SG&A124135185318183444148168120931145536411923582472141551391522381702733183032583293543311,031390548522
Tax00000000000000000000000000000000
Net Income-348-699-670-592-734-1,978-276-334-369-313-359-929-741-501-595-958-501-780-614-417-555-647-516-621-266-462-433-379-371-1,034-429-610-1,079
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-404-566-249-435-296-226-281-299-284-316-360-294-338-644-539-521-509-612-326-402-480-470-329-338-460-284-498-272-165-379-330-588
Cash Investing50045027075000000-1,188300680-1,103193600420-767-1831,05400000
Cash Financing00332,46800000001,412001,737315001,167581001,0001,500180003